Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-003181
Filing Date
2023-03-08
Accepted
2023-03-08 17:31:02
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221231x10k.htm   iXBRL 10-K 1294229
2 EX-4.6 tmb-20221231xex4d6.htm EX-4.6 7003
3 EX-21.1 tmb-20221231xex21d1.htm EX-21.1 1469
4 EX-23.1 tmb-20221231xex23d1.htm EX-23.1 5900
5 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 10055
6 EX-31.2 tmb-20221231xex31d2.htm EX-31.2 10049
7 EX-32.1 tmb-20221231xex32d1.htm EX-32.1 6511
8 EX-32.2 tmb-20221231xex32d2.htm EX-32.2 6530
9 GRAPHIC tmb-20221231x10k001.jpg GRAPHIC 4276
10 GRAPHIC tmb-20221231xex23d1003.jpg GRAPHIC 4591
  Complete submission text file 0001558370-23-003181.txt   5484550

Data Files

Seq Description Document Type Size
11 EX-101.SCH tmb-20221231.xsd EX-101.SCH 45618
12 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 26628
13 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 199408
14 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 373117
15 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 338565
68 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10k_htm.xml XML 744019
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41264 | Film No.: 23717338
SIC: 2834 Pharmaceutical Preparations